Document:

Exhibit 10.14

 

August 1, 2005

 

Mr. Herb
Bellucci

3646 Seahorn Circle

San Diego, CA 92130

Dear Herb:

I am very pleased to provide
you with a summary of the terms of your employment with Alphatec Spine, Inc. (“Alphatec”).
Your employment with Alphatec will commence once any conditions set forth in
this letter are satisfied, and you return the letter to the Company. At this
time, we anticipate that your employment to be effective August 1, 2005.

1.             Position  Your
position will be Vice President, Manufacturing. As you progress with Alphatec,
your position and assignments are, of course, subject to change. As an Alphatec
employee, we expect that you will perform any and all duties and
responsibilities normally associated with your position in a satisfactory manner
and to the best of your abilities at all times.

2.             Starting Date/Nature of Relationship  If you accept this offer, and any conditions
set forth herein are satisfied, your employment with Alphatec will begin on
August 1, 2005 (the “Commencement Date”). Thereafter, you will be expected to
devote all of your working time to the performance of your duties at Alphatec
throughout your employment. No provision of this letter shall be construed to
create an express or implied employment contract, or a promise of employment
for any specific period of time. Your employment with Alphatec is at-will
employment which may be terminated by you or Alphatec at any time for any
reason with or without advance notice.

3.             Compensation, Equity, Benefits, Bonus  Your initial base pay shall be at a rate of $
3,846.15 weekly ($200,000.00 on an annualized basis) minus customary deductions
for federal and state taxes and the like.

Subject to approval by the
Board of Directors, you will be granted 10,000 shares of Founder’s stock. This
stock will have a five year vesting schedule along with change of control
privileges.

In addition to your
compensation, you may choose to take advantage of various health and welfare
benefits offered by Alphatec to include a 401(k) plan. These benefits, of
course, may be modified or changed from time to time at the sole discretion of
Alphatec. Any provision of benefits to you in no way changes or impacts your
status as an at-will employee.

Employee will be eligible to
receive a cash performance bonus each fiscal year, payable within 30 days after
the end of the Company’s fiscal year, in an amount of up to 20% of the base
salary received by Employee for such fiscal year. In the fiscal year ended
December 31, 2005 (“FY 2005”), Employee will be entitled to his full
performance bonus (which will be 20% of base salary paid from the Commencement
Date through December 31, 2005) if the Company’s Net Sales (as that term is
used in the Company’s audited financial statements), exclusive of sales by
businesses acquired from and after the Commencement Date equal or exceed $50
Million. In

 

 

the event that
Same Store Sales in FY 2005 are $33 Million, Employee will receive 25% of his
full performance bonus. In the event that Same Store Sales in FY 2005 are $40
Million, Employee will receive 50% of his full performance bonus. In the event
that Same Store Sales for FY 2005 are between $33 Million and $40 Million, the
percentage of Employee’s full performance bonus shall be prorated between 25%
and 50%, and in the event that Same Store Sales for FY 2005 are between $40
Million and $50 Million, such percentage shall be prorated between 50% and
100%. After FY 2005, performance bonuses shall be based upon the achievement of
objectives established by the President and COO prior to the commencement of
the fiscal year.

4.             Your Certifications To Alphatec  As a condition of your employment:

You hereby certify to Alphatec
that (1) you are free to enter into and fully perform the duties of your
position and that you are not subject to any employment, confidentiality,
non-competition or other agreement that would restrict your employment by
Alphatec, (2) signing this letter of employment with Alphatec does not violate
any order, judgment or injunction applicable to you, or conflict with or breach
any agreement to which you are a party or by which you are bound, (3) you have
disclosed to Alphatec any applicability agreements that address confidentiality
or other post-employment obligations, (4) all facts you have presented or will
present to Alphatec are accurate and true. This includes, but is not limited
to, all oral and written statements you have made (including those pertaining
to your education, training, qualifications, licensing and prior work
experience) on any job application, resume or c. v.,
or in any interview or discussion with Alphatec.

5.             Non-solicitation/Proprietary Information/Non disclosure

For a period of 12 months upon
termination, the Employee is under a non solicit, non disclosure agreement.
Upon termination of Employee’s employment for any reason, Employee will not
recruit, solicit or induce, or attempt to induce, any Employees of the Company
to terminate their employment with, or otherwise cease their relationship with,
the Company for a period of 12 months.

Employee agrees that all
information and know-how, whether or not in writing, of a private, secret or
confidential nature concerning the Company’s business or financial affairs
(collectively, “Proprietary Information”) is and shall be the exclusive
property of the Company. By way of illustration, but not limitation,
Proprietary Information may include inventions, products, processes, methods,
techniques, formulas, compositions, compounds, projects, developments, plans,
research data, clinical data, financial data, personnel data, computer
programs, and customer and supplier lists. Employee will not disclose any
Proprietary Information to others outside the Company or use the same for any
unauthorized purposes without written approval by an officer of the Company,
either during or after his employment, unless and until such Proprietary
Information has become public knowledge without fault by Employee.

Employee agrees that all files,
letters, memoranda, reports, records, data, sketches, drawings, laboratory
notebooks, program listings, or other written, photographic, or other tangible
material containing Proprietary Information, whether created by Employee or
others, which shall come into his custody or possession, shall be and are the
exclusive property of the Company to be used by Employee only in the
performance of his duties for the Company.

 

 

2

 

Employee agrees that his
obligation not to disclose or use information, know-how and records of the
types set forth in paragraphs (a) and (b) above, also extends to such types of
information, know-how, records and tangible property of subsidiaries and joint
ventures of the Company, customers of the Company or suppliers to the Company
or other third parties who may have disclosed or entrusted the same to the
Company or to Employee in the course of the Company’s business.

6.             Termination
by the Company Without Cause 
In the event that Employee’s employment is terminated without cause the
Company shall continue for a period of 3 months (“Severance Period”) to pay to
Employee his annual base salary then in effect.

7.             Protection of Alphatec in Connection with Your Termination by Digirad

You acknowledge that an
important factor in our decision to hire you as Vice President - Manufacturing
was the information you provided to us concerning the circumstances surrounding
the termination of your employment by Digirad Corporation (“Digirad”). You
hereby represent to us that such information was truthful and accurate and did
not omit material facts necessary to make the information you provided us not
misleading. You hereby agree that if, at any time through December 31, 2006
your prior employment relationship with Digirad objectively exposes Alphatec to
potential liability, or if during such period we learn of additional facts
concerning your termination by Digirad that reasonably cause us to believe it
would be detrimental to Alphatec to continue your employment, we will have the
right to terminate your employment upon 14 days’ prior notice, to which you
will be given a reasonable opportunity to respond in writing and defend and
remove the action during the notice period, in which event you will not be
entitled to severance pay hereunder, and you will be required to transfer back
to Alphatec all stock and options issued to you at the time we terminate your
employment at a purchase price equal to the price per share or option you paid
for such stock or options.

8.             Miscellaneous  This letter constitutes Alphatec’s entire
offer regarding the terms and conditions of your prospective employment with
Alphatec. It supersedes any prior agreements, or other promises or statements
(whether oral or written) regarding the offered terms of employment.

You may accept this offer of
employment and the terms and conditions hereof by signing the enclosed
additional copy of this letter. Your signature on the copy of this letter and
your submission of the signed copy to me will evidence your agreement with the
terms and conditions set forth herein.

 

	
  Sincerely,

  	
   

  
	
   

  	
   

  
	
  /s/ Ronald G. Hiscock

  	
   

  
	
   

  	
   

  
	
  Ronald G. Hiscock

  	
   

  
	
  President and Chief Operating Officer

  	
   

  
	
   

  	
   

  

 

 

3

 

 

Agreed to and
Acknowledged:

	
  /s/ Herbert J. Bellucci

  
	
  Signature

  
	
   

  
	
  Date: August 1, 2005

  

 

 

4Exhibit
10.15

 

EXECUTIVE
SERVICES AGREEMENT

 

THIS EXECUTIVE
SERVICES AGREEMENT (this “Agreement”), made this 11th day of August,
2005, is entered into by Alphatec Spine Inc., a California corporation (the “Company”),
and Shunshiro Yoshimi (“Yoshimi”), residing at 25-7 Asumigaoka, 7
Chome, Midori-ku, Chiba-shi, Chiba-ken

 

WHEREAS, the Company and Yoshimi desire to
enter into an executive services agreement which will supersede any such prior
agreements; and

 

WHEREAS, the Company wishes Yoshimi to
perform services for Alphatec Pacific, Inc., a Japanese corporation and
subsidiary of the Company (“API”);

 

WHEREAS, the Company and Yoshimi have entered
into negotiations concerning this Agreement at the offices of
HealthpointCapital, LLC in New York City.

 

NOW, THEREFORE, in consideration of the
mutual covenants and promises contained herein and other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged by
the parties hereto, the parties agree as follows:

 

1.             Term.  The Company hereby agrees to retain Yoshimi,
and Yoshimi hereby agrees to be retained by the Company, upon the terms set
forth in this Agreement, for the period commencing on March 25, 2005 (the “Commencement
Date”) and ending on the first anniversary of the Commencement Date (the “Initial
Term”), unless sooner terminated in accordance with the provisions of Section 4;
provided, however, that upon the expiration of the Initial Term, unless Company
shall have previously notified Yoshimi otherwise, Yoshimi’s retention shall
continue on a month-to-month basis, terminable by Company or Yoshimi as
hereafter provided (the Initial Term, as it may be extended, is referred to
herein as the “Term”).

 

2.             Title; Capacity.  Yoshimi shall serve as the Representative
Director, President and Chief Executive Officer of API to perform the duties
and responsibilities inherent in such position including, but not limited to,
negotiating and restructuring API’s relationships with its distributors in
order to maximize the benefits that accrue to API through these
relationships.  The Company and Yoshimi
agree that Yoshimi shall endeavor to restructure the business of API such that
API will sell its products to customers without the use of a distributor.  To this end, Yoshimi shall endeavor to hire
employees from API’s current distributor in order to run API’s distribution
operation, to the extent permitted by law or such distribution.  The Company and Yoshimi further agree that
Yoshimi shall endeavor to cause API to repurchase inventory that API has sold
to its distributors on a “pay-as-we-go” basis.  Thereafter,
Yoshimi shall endeavor to build an organization at API which, over a period of
approximately 24 months, would include identifying and training a successor to
assume the position of CEO of API and lead the business to continuing
growth.  The manner of the performance of Yoshimi’s services hereunder and the
amount of time Yoshimi spends in Japan or elsewhere in so providing such
services shall be solely within the discretion and determination of Yoshimi,
subject to the authority of the Board of Directors of the Company and
provisions of Section 4.2.  In the
event that (except in connection with grooming a successor CEO as contemplated
above) Yoshimi’s title, authority or

 

 

duties are changed or
diminished, or that the geographical region where Yoshimi provides his services
is altered, or that another person is appointed by API with comparable or more
senior executive title, authority or duties, such action or actions shall be
considered a termination by the Company without cause pursuant to Section 4.2.  It is contemplated that the Term will end
upon the election of the successor CEO with the consent of Yoshimi.

 

3.             Compensation and Benefits.

 

3.1           Compensation.  The Company shall pay Yoshimi annual base
compensation of $200,000, commencing on the Commencement Date, payable in accordance
with the Company’s customary payroll practices.

 

3.2           Fringe
Benefits.  Yoshimi shall be entitled
to participate in all benefit programs that the Company establishes and makes
available to its management employees, if any, to the extent that Yoshimi’s
position, tenure, compensation, age, health and other qualifications make him
eligible to participate, including, but not limited to, health care plans, life
insurance plans, dental care plans, disability income plans, supplemental
retirement plans, and all other benefit plans from time to time in effect
generally for executives and/or employees of the Company.  Yoshimi shall also be subject to
indemnification by the Company and be covered under the Company’s officers and
directors liability insurance and other liability insurance to the fullest
extent provided to any officer or director of the Company.

 

3.3           Reimbursement
of Expenses.  Yoshimi shall be
entitled to reimbursement for reasonable travel, entertainment and other
expenses incurred or paid by him in connection with, or related to the
performance of his duties, responsibilities or services under this Agreement,
upon presentation by Yoshimi of documentation, expense statements, vouchers
and/or such other supporting information as the Company may request.

 

4.             Termination of Retention Period.  This Agreement, and Yoshimi’s services
hereunder, shall terminate upon the occurrence of any of the following:

 

4.1           Termination
for Cause.  At the election of the
Company, for Cause.  For the purposes of
this Section 4.1, “Cause” for termination shall be deemed to exist upon
the occurrence of any of the following:

 

(a)           a
finding by the Company that Yoshimi has engaged in dishonesty, gross negligence
or gross misconduct that is injurious to the Company;

 

(b)           Yoshimi’s
conviction or entry of nolo contendere to any felony or crime involving moral
turpitude, fraud or embezzlement of Company property; or

 

(c)           Yoshimi’s
failure to provide any of the services set forth in Section 2 herein, or
any other material breach of this Agreement, which, if curable, has not been
cured by Yoshimi within 30 days after he shall have received written notice
from the Company stating with reasonable specificity the nature of such breach.

 

4.2           Termination
by the Company Without Cause.  At the
election of the Company, without Cause, at any time.  Any material breach of this Agreement by the
Company

 

2

 

which, if curable, has not been cured by the
Company within 30 days after receiving written notice from Yoshimi stating with
reasonable specificity the nature of such breach shall be deemed to be a
termination without Cause by the Company.

 

4.3           Death
or Disability.  Upon the death or a
determination of disability of Yoshimi. 
As used in this Agreement, the determination of “disability” shall occur
when Yoshimi, due to a physical or mental disability, for a period of 90
consecutive days, or 180 days in the aggregate whether or not consecutive,
during any 360-day period, is unable to perform the services contemplated under
this Agreement.  A determination of
disability shall be made by a physician satisfactory to both Yoshimi and the
Company, provided  that if Yoshimi and the Company do not agree on
a physician, Yoshimi and the Company shall each select a physician and these
two together shall select a third physician, whose determination as to
disability shall be binding on all parties.

 

4.4           Voluntary
Termination by Yoshimi.  At the election of Yoshimi,
other than pursuant to Sections 4.2, 4.3 or as a result of any material breach
of this agreement by the Company which is not cured within thirty (30) days of
receiving notice from Yoshimi, stating with reasonable specificity the nature
of such breach, upon not less than 30 days prior written notice by him to the
Company.

 

5.             Effect of Termination.

 

5.1           Termination
for Cause, at the Election of Yoshimi or for Death of Disability.  In the event that Yoshimi’s services are
terminated for Cause pursuant to Section 4.1, for death or disability
pursuant to Section 4.3 or at the election of Yoshimi pursuant to Section 4.4,
the Company shall have no further obligations under this Agreement other than
to pay to Yoshimi the compensation and benefits, including payment for accrued
but untaken vacation days, otherwise payable to him under Section 3
through the last day of his actual retention by the Company.

 

5.2           Termination
by the Company Without Cause.

 

(a)           In
the event that Yoshimi’s services are terminated pursuant to Section 4.2,
the Company shall continue to pay to Yoshimi his annual base compensation then
in effect for twelve (12) months in the manner set forth in Section 3.1
and payment for accrued but untaken vacation days.  In addition, the Company shall continue its
contributions toward Yoshimi’s health care, dental, disability and life
insurance benefits for a period of twelve months from the last day of Yoshimi’s
retention or for the remainder of time left in the Agreement Term, whichever is
greater.  Notwithstanding the foregoing,
the Company shall not be required to provide any health care, dental,
disability or life insurance benefit otherwise receivable by Yoshimi pursuant
to this Section 5.2 if Yoshimi is actually covered by an equivalent
benefit (at the same cost to Yoshimi, if any) from another employer during
which continuing benefits are provided pursuant to this Section 5.2.  Any such benefit made available to Yoshimi
shall be reported to the Company.  The amounts
paid under this Section 5.2 shall be in lieu of, and not in addition to,
any severance benefits for which Yoshimi would be otherwise eligible.  The benefits provided for in this Section are
conditioned upon the execution by Yoshimi of a release in a form satisfactory
to the Company with respect to the matters covered in this Section 5.2(a).

 

3

 

6.             Nondisclosure.

 

6.1           Proprietary
Information.

 

(a)           Yoshimi
agrees that all information and know-how, whether or not in writing, of a
private, secret or confidential nature concerning the Company’s or API’s
business or financial affairs (collectively, “Proprietary Information”) is and
shall be the exclusive property of the Company and/or API.  By way of illustration, but not limitation,
Proprietary Information may include inventions, products, processes, methods,
techniques, formulas, compositions, compounds, projects, developments, plans,
research data, clinical data, financial data, personnel data, computer programs,
and customer and supplier lists.  Yoshimi
will not disclose any Proprietary Information to others outside the Company and
API or use the same for any unauthorized purposes, either during or after his
retention, unless and until such Proprietary Information has become public
knowledge without fault by Yoshimi. 
Proprietary Information shall not include information and know-how that,
prior to the execution of this Agreement, has entered the public domain or has
been disclosed to the public by the Company or lawfully by others, and shall
not include information and know-how required to be disclosed by law,
regulation or other governmental requirement.

 

(b)           Yoshimi
agrees that all files, letters, memoranda, reports, records, data, sketches,
drawings, laboratory notebooks, program listings, or other written,
photographic, or other tangible material containing Proprietary Information,
whether created by Yoshimi or others, which shall come into his custody or
possession, shall be and are the exclusive property of the Company to be used
by Yoshimi only in the performance of his duties for the Company.

 

(c)           Yoshimi
agrees that his obligation not to disclose or use information, know-how and
records of the types set forth in paragraphs (a) and (b) above, also
extends to such types of information, know-how, records and tangible property
of subsidiaries and joint ventures of the Company and API, customers of the
Company and API or suppliers to the Company or other third parties who may have
disclosed or entrusted the same to the Company or API or to Yoshimi in the
course of the Company’s or API’s business.

 

6.2           Noncompetition
and Non-solicitation.  As a necessary
measure to protect any intellectual property, proprietary information, trade
secrets, know-how and other data or information owned or developed by API,
Yoshimi agrees that:

 

(a)           During
his retention by the Company hereunder and for one (1) year thereafter,
Yoshimi shall not, directly or indirectly, render services of a business,
professional or commercial nature to any other person or entity that competes
with the Company’s or API’s business, whether for salary or otherwise, or
engage in any business activities competitive with the Company’s business,
whether alone, as an employee, as a partner, or as a shareholder (other than as
the holder of not more than one percent of the combined voting power of the
outstanding stock of a public company), officer or director of any corporation
or other business entity, or as a trustee, fiduciary or in any other similar representative
capacity of any other entity, within Japan. 
Notwithstanding the foregoing, the expenditure of reasonable amounts of
time as a member of other companies’ Board of Directors shall not be deemed a

 

4

 

breach of this if those activities do not
materially interfere with the services required under this Agreement; and

 

(b)           For
a period of one (1) year after termination of Yoshimi’s services for any
reason, Yoshimi will not recruit solicit or induce, or attempt to induce, any
employee or employees of the Company or API to terminate their employment with,
or otherwise cease their relationship with, the Company or API.

 

6.3           If
any restriction set forth in this Section 6 is found by any court of
competent jurisdiction to be unenforceable because it extends for too long a
period of time or over too great a range of activities or in too broad a
geographic area, it shall be interpreted to extend only over the maximum period
of time, range of activities or geographic area as to which it may be
enforceable.

 

6.4           The
restrictions contained in this Section 6 are necessary for the protection
of the business and goodwill of the Company and are considered by Yoshimi to be
reasonable for such purpose.  Yoshimi
agrees that any breach of this Section 6 will cause the Company
substantial and irrevocable damage and therefore, in the event of any such
breach, in addition to such other remedies which may be available, the Company
shall have the right to seek specific performance and injunctive relief.

 

6.5           Other
Agreements.  Yoshimi represents that
his performance of all the terms of this Agreement does not and will not breach
any (i) agreement to keep in confidence proprietary information, knowledge
or data acquired by him in confidence or in trust prior to his retention by the
Company or (ii) agreement to refrain from competing, directly or
indirectly, with the business of any previous employer or any other party.

 

7.             Notices.

 

7.1           All
notices under this Agreement must be in writing and may be given by personal
delivery, telex, telegram, private courier service or registered or certified
mail.

 

7.2           A
notice is deemed to have been given:

 

(a)           by
personal delivery or private courier service, as of the day of delivery of the
notice to the addressee; and

 

(b)           by
mail, as of the fifth (5th) day after the notice is mailed.

 

5

 

7.3           Notices
must be sent to:

 

(i)           
if to the Company, to:

 

Alphatec Spine Inc.

6110 Corte Del Cedro

Carlsbad, CA 92009

Telecopier: (760) 431-1573

Attention: Chief Executive Officer

 

with a copy to:

 

Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.

Chrysler Center

666 Third Avenue

New York, New York 10017

Attention:  Stephen C. Curley, Esq.

 

(ii)           if
to Yoshimi, to:

 

Shunshiro Yoshimi

25-7 Asumigaoka, 7 Chome

Midori-ku

Chiba-shi

Chiba-ken

 

with a copy to:

 

Jacobson, Mermelstein & Squire, LLP

52 Vanderbilt Avenue

New York, New York  10017

Attention:  Walter C. Squire, Esq.

 

8.             Arbitration.  Any controversy or claim arising out of or
relating to this Agreement, or the breach thereof, shall be settled exclusively
by arbitration in accordance with the Rules of the American Arbitration
Association (“AAA”), before a panel of three (3) arbitrators.  The arbitrators shall be chosen by mutual
agreement of Buyer and Seller or if they cannot agree, by the AAA.  The arbitrators shall be required to apply
and shall be bound by applicable New York State and federal law in rendering
their decision.  The determination of the
arbitration shall be conclusive and binging, and judgment upon the award
rendered by the arbitrators may be entered in any court having jurisdiction
thereof.  The arbitration shall take
place in New York City.  Each party shall
bear its own costs incurred in connection with any such arbitration, and the
fees and expenses of the arbitrators shall be shared equally by the Company and
Yoshimi.

 

6

 

9.             Pronouns.  Whenever the context may require, any
pronouns used in this Agreement shall include the corresponding masculine,
feminine or neuter forms, and the singular forms of nouns and pronouns shall
include the plural, and vice versa.

 

10.           Entire Agreement.  This Agreement, and those documents
referenced herein, constitute the entire agreement between the parties and
supersedes all prior agreements and understandings, whether written or oral
relating to the subject matter of this Agreement.

 

11.           Amendment.  This Agreement may be amended or modified
only by a written instrument executed by both the Company and Yoshimi.

 

12.           Governing Law.  This Agreement shall be construed,
interpreted and enforced in accordance with the laws of the State of New York.

 

13.           Successors and Assigns.

 

13.1         Assumption
by Successors.  Any successor shall
succeed to all of the Company’s duties, obligations, rights and benefits
hereunder.  The Company shall require any
successor (whether direct or indirect, by purchase, merger, consolidation or
otherwise and whether or not after a Change in Control) to all or substantially
all of the business or assets of the Company to assume in writing prior to such
succession and to agree to perform its obligations under this Agreement in the
same manner and to the same extent that the Company would be required to perform
it if no such succession had taken place.

 

13.2         Successor
Benefits.  This Agreement shall be
binding upon and inure to the benefit of both parties and their respective
successors and assigns, including any corporation into which the Company may be
merged or which may succeed to its assets or business, provided, however,
that the obligations of Yoshimi are personal and shall not be assigned by him.

 

14.           Miscellaneous.

 

14.1         No
Waiver.  No delay or omission by the
Company in exercising any right under this Agreement shall operate as a waiver
of that or any other right.  A waiver or
consent given by the Company on any one occasion shall be effective only in
that instance and shall not be construed as a bar or waiver of any right on any
other occasion.

 

14.2         Captions.  The captions of the sections of this
Agreement are for convenience of reference only and in no way define, limit or
affect the scope or substance of any section of this Agreement.

 

14.3         Severability.  In case any provision of this Agreement shall
be invalid, illegal or otherwise unenforceable, the validity, legality and
enforceability of the remaining provisions shall in no way be affected or
impaired thereby.

 

14.4         Counterparts.  This Agreement may be executed in two or more
counterparts, each of which shall be deemed an original but all of which
together shall constitute one and the same instrument.

 

7

 

IN WITNESS WHEREOF, the parties hereto have
executed this Agreement as of the day and year set forth above.

 

	
   

  	
  /s/ Shunshiro Yoshimi

  
	
   

  	
  Shunshiro Yoshimi

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  ALPHATEC SPINE INC.

  
	
   

  	
   

  
	
   

  	
  By:

  	
  /s/ John H. Foster

  
	
   

  	
   

  	
  Title: 
  Chief Executive Officer

  

 

8

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00097-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00097-of-00352.parquet"}]]